Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
26,261,349
-
Share change
-
-290,778
-
Total reported value
-
$417,714,570
-
Price per share
-
$15.91
-
Number of holders
-
133
-
Value change
-
-$3,528,116
-
Number of buys
-
80
-
Number of sells
-
47
Institutional Holders of SAGENT PHARMACEUTICALS INC - COM (SGNT) as of Q4 2015
As of 31 Dec 2015,
SAGENT PHARMACEUTICALS INC - COM (SGNT) was held by
133 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
26,261,349 shares.
The largest 10 holders included
FRANKLIN RESOURCES INC, BlackRock Fund Advisors, VANGUARD GROUP INC, HealthCor Management, L.P., EverPoint Asset Management, LLC, PENN CAPITAL MANAGEMENT CO INC, EAGLE ASSET MANAGEMENT INC, Sectoral Asset Management Inc, MILLENNIUM MANAGEMENT LLC, and JPMORGAN CHASE & CO.
This page lists
133
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.